Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection ; volume:13 ; number:1 ; day:7 ; month:1 ; year:2013 ; pages:1-8 ; date:12.2013
BMC neurology ; 13, Heft 1 (7.1.2013), 1-8, 12.2013
- Creator
-
Bremell, Daniel
- Contributor
-
Mattsson-Carlgren, Niklas
Edsbagge, Mikael
Blennow, Kaj
Andréasson, Ulf
Wikkelsö, Carsten
Zetterberg, Henrik
Hagberg, Lars
SpringerLink (Online service)
- DOI
-
10.1186/1471-2377-13-2
- URN
-
urn:nbn:de:1111-2016030333159
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bremell, Daniel
- Mattsson-Carlgren, Niklas
- Edsbagge, Mikael
- Blennow, Kaj
- Andréasson, Ulf
- Wikkelsö, Carsten
- Zetterberg, Henrik
- Hagberg, Lars
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease